ArthurMBobroveMD

Rheumatology • Palo Alto, CA

Palo Alto Medical Foundation Emeritus

Join to view full profile

Dr. Bobrove is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bobrove's full profile

Already have an account?

Office
3801 Miranda Ave
Palo Alto, CA 94304
Phone+1 650-493-5000

Education & Training

Stanford University Medical SchoolFellowship, 1972 - 1974
University of MichiganResidency, Internal Medicine, 1970 - 1972
University of Michiganresidency, 1970 - 1972
University of MichiganInternship, Internal Medicine, 1967 - 1968
Lewis Katz School of Medicine at Temple UniversityClass of 1967
Temple UniversityAB, Mathematics, 1962 - 1963

Certifications & Licensure

MI State Medical License 1971 - Present
CA State Medical License 1970 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology
FACIM FACR

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Fellow (FACR) American College of Rheumatology

Publications & Presentations

PubMed

115 citations
Quantitation of T and B lymphocytes and cellular immune function in Hodgkin's disease.
Arthur M. Bobrove, Zvi Fuks, Samuel Strober, Henry S. Kaplan
Cancer. 1975-07-01
64 citations
Nonsteroidal Anti-inflammatory Agents in Rheumatoid Arthritis and Ankylosing Spondylitis
Cody Wasner, Melvin C. Britton, R. Guy Kraines, Ronald L. Kaye, Arthur M. Bobrove
JAMA. 1981-11-13
74 citations
Rheumatoid nodules: Review of the spectrum of associated conditions and proposal of a new classification, with a report of four seronegative cases
Brian R. Kaye, Ronald L. Kaye, Arthur M. Bobrove
The American Journal of Medicine. 1984-02-01

Other

Craniofacial hyperdrosis and masking during COVID: effectiveness of glycopyrronium tosylate cloth
Arthur M Bobrove, MD and Jeffrey D Urman, MD
10/2022

Press Mentions

In Memoriam: Samuel Strober, MDApril 15th, 2022

Research History

Principal InvestigatorTopical Glycopyrrolate to treat idiopathic hyperhidrosis.2005 - 2007

Professional Memberships

American College of Rheumatology - ACR
Fellow